Weight Loss Injections in Reno and Everywhere Else: The Real Picture

The biggest misconception: these injections are an easy option people take instead of trying

A question our prescribers hear most weeks goes something like: 'I don't want the injection, I just need a bit of help, are these for people who've given up on diet and exercise?' The premise is backwards. Both Mounjaro and Wegovy are licensed to be used alongside a reduced-calorie diet and increased physical activity, not as replacements for them. What they change is the biology that makes sticking to that plan so difficult. Tirzepatide activates two gut-hormone receptors (GIP and GLP-1) to reduce appetite, slow how quickly the stomach empties, and improve blood-sugar regulation. Semaglutide targets the GLP-1 receptor alone. In both cases, the result for many people is that hunger becomes noticeably quieter; the pull toward oversized portions or late-night eating simply diminishes. That's a physiological change, not a willpower shortcut. The SURMOUNT-1 trial, published in the New England Journal of Medicine, reported average body-weight reductions of around 20–21% at the highest tirzepatide dose over 72 weeks in adults with obesity. That kind of result doesn't come from the injection alone, it comes from the weight loss injection making the recommended lifestyle changes achievable for people whose biology had previously fought against them.

What the eligibility criteria actually require (and why BMI is only part of it

Both medicines carry a UK licence for adults with a BMI of 30 or above, or 27 and above where at least one weight-related health condition is present) things like high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. For some people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, NICE guidance applies thresholds 2.5 kg/m² lower. You can get a rough sense of where you stand with the NHS BMI calculator, but a number on a screen doesn't account for your medication history, existing conditions, or anything else a prescriber needs to consider. A BMI that technically qualifies you doesn't guarantee approval; a BMI slightly below the threshold doesn't automatically rule you out if a relevant condition is present. The assessment is clinical, not algorithmic. Those who want to understand the broader landscape of licensed weight loss injections in the UK can find a thorough overview there.

Side effects: what's normal, what to watch, and what needs urgent attention

Gastrointestinal symptoms are the most reported effects of both medicines: nausea, loose stools, constipation, reflux, and occasional vomiting. For most people these are most pronounced in the early weeks and after each dose increase, and they settle as the body adjusts. Fatigue, mild headache, and injection-site reactions also appear in the clinical-trial data. None of that should be minimised or overstated, it's real, and it's worth knowing in advance. What matters more is recognising the signs that require prompt medical attention. In January 2026, the MHRA issued a Drug Safety Update flagging acute pancreatitis as a known but infrequent risk with GLP-1 medicines: severe, persistent abdominal pain that radiates to the back, with or without vomiting, needs same-day medical assessment. Gallbladder problems, symptoms of dehydration from severe illness, and signs of a serious allergic reaction also fall into the 'seek help now' category. Patients can report suspected side effects directly through the MHRA Yellow Card scheme. If you want a fuller comparison of how the two injections differ on tolerability and results, the three-injection comparison page covers the evidence clearly. For the cost side of the conversation, the price context page sets out what legitimate private treatment typically involves, without glossing over the gaps that some headline prices leave out.

How the prescription process works, and what makes an online pharmacy legitimate

Both Mounjaro and Wegovy are available privately through regulated online pharmacies. 'Regulated' has a specific meaning: the pharmacy holds a GPhC premises registration that anyone can verify on the GPhC public register. Medicines must come through the licensed UK supply chain. A GPhC-registered Independent Prescriber must personally review your consultation (not software, not a template) before any prescription is issued. At nume, that review happens the same day, and once approved, treatment is dispatched the same working day for free next-working-day delivery via DPD. People who are already on treatment elsewhere and want to transfer their care, or those asking about getting an injection without going through their GP, often find a regulated private pharmacy the most practical option. It's also worth knowing what makes a seller illegitimate: offering these medicines without a valid prescription, through social media, or at prices far below the established market range are all red flags the MHRA has explicitly warned about. The difference between a verified pharmacy and an unverified seller is not a trivial one, counterfeit pens have caused real harm. Our about page explains how we operate, and our clinical team profile (including our lead prescriber) is published openly for anyone who wants to check. If you have questions before starting, our FAQs cover the most common ones, and patients curious about how GP weight loss injections compare to private prescribing will find that covered in detail too. When you're ready to take the next step, speak to our prescribers through a free consultation, no obligation, no commitment until treatment is right for you.